Skip to content

AARD AARD Increase (Decrease) in Prepaid Expense and Other Assets

Increase (Decrease) in Prepaid Expense and Other Assets at other companies

Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$487K-84.8%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$340K+180%
Viking Therapeutics logo
Viking TherapeuticsVKTX
-$4.63M-148%
Arvinas logo
ArvinasARVN
$600K-77.8%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$1.92M+102%
AbbVie logo
AbbVieABBV

Other financials

Income statement

See full
Revenue-
Operating income-$22.5M-115%
Net income-$21.6M-132%
EPS (diluted)-$0.99-39.4%

Balance sheet

See full
Cash & equivalents$62.4M+136%
Total debt$336.0K-53.7%
Total equity$87.0M-42.3%
Total assets$98.6M-37.2%

Cash flow

See full
Operating cash flow-$18.9M-65.7%
CapEx--100%
Free cash flow-$16.8M-117%

Valuation

See full
Market cap$124.35M-58.6%
Enterprise value$62.25M-77.4%

Returns & leverage

See full
Return on equity-58.8%
Debt / equity0.0×
Current ratio8.1×-17.8×

Where this comes from

Reported directly by AARD in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's increase (decrease) in prepaid expense and other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AARD's increase (decrease) in prepaid expense and other assets?
AARD (AARD) reported increase (decrease) in prepaid expense and other assets of $333K in Q1 2026.
How has AARD's increase (decrease) in prepaid expense and other assets changed year-over-year?
AARD's increase (decrease) in prepaid expense and other assets decreased by 92.4% year-over-year, from $4.36M to $333K.
What does increase (decrease) in prepaid expense and other assets mean?
This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.